Preventive Medicine
Canine Adenovirus Type 2 Vaccination
CAV-2 is endemic in healthy dog populations worldwide and is a significant viral cause of CIRD, particularly when combined with viral or bacterial co-infections.
Menu

CAV-2 is endemic in healthy dog populations worldwide and is a significant viral cause of CIRD, particularly when combined with viral or bacterial co-infections.




This rare case of adrenal-dependent AHAC provides evidence that trilostane therapy may effectively manage associated clinical signs and improve quality of life if surgical intervention is not pursued.

Although compulsive disorder is a relatively rare diagnosis for cats, this behavior can lead to a significantly decreased quality of life for both cat and owner.

Careful diagnostic evaluation and routine use of acaricides help mitigate infestation with this common parasite.

Although this step-by-step guide can help clinicians make enteral nutrition plans, it is just a starting point.

This overview on the leptospirosis vaccine goes over the basics, as well as serovars, serogroups, and sequence types.

Half the battle of treating otitis externa is figuring out the underlying cause and type.
Stay current with the latest techniques and information – sign up below to start your FREE Today’s Veterinary Practice subscription today.
Start My SubscriptionTo provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
